On the contrary, middle or high methylation of SPON2 promoter resulted in low expression of SPON2, which was strongly correlated with favorable outcome of patients with acute lymphoblastic leukemia [34]. This evidence concerns the gene SPON2 and acute lymphoblastic leukemia.